DaVita Inc.DVANYSE

Overview Intelligence Charts News Fundamentals Key Metrics Financials Growth Insiders

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating

Hold

22 analysts·High coverage

36%

Rating Distribution

Strong Buy

00%

Buy

836%

Hold

1359%

Sell

15%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 9% higher.

Bear Case

$158.00

+2%

Consensus

$168.67

+9%

Bull Case

$190.00

+23%

Price Range22 analysts

Low

Consensus

High

$158.00

$190.00

Current Target

Current Price

$154.77

Upside to Target

$13.90

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$14.13(4 analysts)

P/E18x

Current: 17.6x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+2.92%

EPS+15.14%

FY2028

Rev+2.85%

EPS+12.38%

FY2029

Rev+7.33%

EPS-0.93%

Earnings Surprises

Beat rate:75%(9/12 quarters)

Avg surprise:+5.3%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 5, 2026Truist Financial

DaVita price target raised to $158 from $128 at Truist

Target:$158.00

+9.4%from $144.41

Feb 4, 2026UBS

DaVita price target raised to $190 from $186 at UBS

Target:$190.00

+41.0%from $134.73

Feb 3, 2026Barclays

DaVita price target raised to $158 from $143 at Barclays

Target:$158.00

+42.1%from $111.19

Oct 30, 2025Barclays

DaVita price target lowered to $143 from $149 at Barclays

Target:$143.00

+13.0%from $126.56

Oct 14, 2025Truist Financial

DaVita price target lowered to $140 from $148 at Truist

Target:$140.00

+13.5%from $123.36

Oct 9, 2025Barclays

DaVita price target lowered to $149 from $160 at Barclays

Target:$149.00

+16.5%from $127.89

Aug 8, 2025Truist Financial

DaVita price target lowered to $148 from $164 at Truist

Target:$148.00

+14.3%from $129.54

Feb 21, 2025Bernstein

Warren Buffett's Berkshire Hathaway Sells $116M Shares Of Dialysis Giant DaVita, Cuts Stake By 2%

Target:$184.00

+29.2%from $142.40

Aug 7, 2024Bank of America Securities

DaVita price target raised to $145 from $139 at BofA

Target:$145.00

+8.6%from $133.53

May 6, 2024Barclays

DaVita price target raised to $150 from $133 at Barclays

Target:$150.00

+11.6%from $134.45

Oct 31, 2022Barclays

DaVita price target lowered to $81 from $103 at Barclays

Target:$81.00

+14.8%from $70.54

Aug 19, 2022UBS

UBS Assumes DaVita (DVA) with a Buy

Target:$117.00

+25.7%from $93.10

Jun 28, 2022Truist Financial

DaVita (DVA) Stock: $90 Target And Hold Rating

Target:$90.00

+13.3%from $79.44

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance